In vivo metabolism of the cardiovascular toxin, allylamine

Paul J. Boor, Radhika Sanduja, Thomas J. Nelson, Ghulam Ansari

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Previous evidence from this laboratory demonstrated that allylamine, a known cardiovascular toxin, is metabolized in vitro to acrolein, which has been hypothesized to act as a distal toxin. In this study, 3-hydroxypropylmercapturic acid was isolated and identified by MS, NMR, and 2D-NMR spectroscopy as the sole urinary metabolite of allylamine metabolism in vivo. Parallel experiments showed reduced glutathione (GSH) depletion in several organs (most marked in aorta, blood, and lung), which is consistent with GSH conjugation of the proposed acrolein intermediate. These findings indicate that allylamine was metabolized in vivo to a highly reactive aldehyde which was converted to a mercapturic acid through a GSH conjugation pathway; the exact mechanisms of cellular damage remain unclear.

Original languageEnglish (US)
Pages (from-to)4347-4353
Number of pages7
JournalBiochemical Pharmacology
Volume36
Issue number24
DOIs
StatePublished - Dec 15 1987

Fingerprint

Allylamine
Metabolism
Acrolein
Acetylcysteine
Metabolites
Aldehydes
Nuclear magnetic resonance spectroscopy
Glutathione
Aorta
Blood
Magnetic Resonance Spectroscopy
Nuclear magnetic resonance
Lung
Experiments

ASJC Scopus subject areas

  • Pharmacology

Cite this

In vivo metabolism of the cardiovascular toxin, allylamine. / Boor, Paul J.; Sanduja, Radhika; Nelson, Thomas J.; Ansari, Ghulam.

In: Biochemical Pharmacology, Vol. 36, No. 24, 15.12.1987, p. 4347-4353.

Research output: Contribution to journalArticle

Boor, Paul J. ; Sanduja, Radhika ; Nelson, Thomas J. ; Ansari, Ghulam. / In vivo metabolism of the cardiovascular toxin, allylamine. In: Biochemical Pharmacology. 1987 ; Vol. 36, No. 24. pp. 4347-4353.
@article{4b8f3c1a583d43f793e6dce12506d544,
title = "In vivo metabolism of the cardiovascular toxin, allylamine",
abstract = "Previous evidence from this laboratory demonstrated that allylamine, a known cardiovascular toxin, is metabolized in vitro to acrolein, which has been hypothesized to act as a distal toxin. In this study, 3-hydroxypropylmercapturic acid was isolated and identified by MS, NMR, and 2D-NMR spectroscopy as the sole urinary metabolite of allylamine metabolism in vivo. Parallel experiments showed reduced glutathione (GSH) depletion in several organs (most marked in aorta, blood, and lung), which is consistent with GSH conjugation of the proposed acrolein intermediate. These findings indicate that allylamine was metabolized in vivo to a highly reactive aldehyde which was converted to a mercapturic acid through a GSH conjugation pathway; the exact mechanisms of cellular damage remain unclear.",
author = "Boor, {Paul J.} and Radhika Sanduja and Nelson, {Thomas J.} and Ghulam Ansari",
year = "1987",
month = "12",
day = "15",
doi = "10.1016/0006-2952(87)90683-6",
language = "English (US)",
volume = "36",
pages = "4347--4353",
journal = "Biochemical Pharmacology",
issn = "0006-2952",
publisher = "Elsevier Inc.",
number = "24",

}

TY - JOUR

T1 - In vivo metabolism of the cardiovascular toxin, allylamine

AU - Boor, Paul J.

AU - Sanduja, Radhika

AU - Nelson, Thomas J.

AU - Ansari, Ghulam

PY - 1987/12/15

Y1 - 1987/12/15

N2 - Previous evidence from this laboratory demonstrated that allylamine, a known cardiovascular toxin, is metabolized in vitro to acrolein, which has been hypothesized to act as a distal toxin. In this study, 3-hydroxypropylmercapturic acid was isolated and identified by MS, NMR, and 2D-NMR spectroscopy as the sole urinary metabolite of allylamine metabolism in vivo. Parallel experiments showed reduced glutathione (GSH) depletion in several organs (most marked in aorta, blood, and lung), which is consistent with GSH conjugation of the proposed acrolein intermediate. These findings indicate that allylamine was metabolized in vivo to a highly reactive aldehyde which was converted to a mercapturic acid through a GSH conjugation pathway; the exact mechanisms of cellular damage remain unclear.

AB - Previous evidence from this laboratory demonstrated that allylamine, a known cardiovascular toxin, is metabolized in vitro to acrolein, which has been hypothesized to act as a distal toxin. In this study, 3-hydroxypropylmercapturic acid was isolated and identified by MS, NMR, and 2D-NMR spectroscopy as the sole urinary metabolite of allylamine metabolism in vivo. Parallel experiments showed reduced glutathione (GSH) depletion in several organs (most marked in aorta, blood, and lung), which is consistent with GSH conjugation of the proposed acrolein intermediate. These findings indicate that allylamine was metabolized in vivo to a highly reactive aldehyde which was converted to a mercapturic acid through a GSH conjugation pathway; the exact mechanisms of cellular damage remain unclear.

UR - http://www.scopus.com/inward/record.url?scp=0023578344&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023578344&partnerID=8YFLogxK

U2 - 10.1016/0006-2952(87)90683-6

DO - 10.1016/0006-2952(87)90683-6

M3 - Article

C2 - 3689456

AN - SCOPUS:0023578344

VL - 36

SP - 4347

EP - 4353

JO - Biochemical Pharmacology

JF - Biochemical Pharmacology

SN - 0006-2952

IS - 24

ER -